$235 Million is the total value of PURA VIDA INVESTMENTS, LLC's 74 reported holdings in Q2 2016. The portfolio turnover from Q1 2016 to Q2 2016 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| OCUL | Exit | OCULAR THERAPEUTIX INC | $0 | – | -6,000 | -100.0% | -0.03% | – |
| CBAY | Exit | CYMABAY THERAPEUTICS INC | $0 | – | -56,000 | -100.0% | -0.04% | – |
| HTBX | Exit | HEAT BIOLOGICS INC | $0 | – | -240,815 | -100.0% | -0.08% | – |
| VNDA | Exit | VANDA PHARMACEUTICALS INC | $0 | – | -67,500 | -100.0% | -0.26% | – |
| CPXX | Exit | CELATOR PHARMACEUTICALS INC | $0 | – | -55,000 | -100.0% | -0.28% | – |
| NXTM | Exit | NXSTAGE MEDICAL INCcall | $0 | – | -50,000 | -100.0% | -0.34% | – |
| FOLD | Exit | AMICUS THERAPEUTICS INCcall | $0 | – | -100,000 | -100.0% | -0.38% | – |
| FLDM | Exit | FLUIDIGM CORP DEL | $0 | – | -125,000 | -100.0% | -0.46% | – |
| SGNT | Exit | SAGENT PHARMACEUTICALS INC | $0 | – | -89,713 | -100.0% | -0.50% | – |
| ANGO | Exit | ANGIODYNAMICS INCcall | $0 | – | -100,000 | -100.0% | -0.56% | – |
| EWA | Exit | ISHAREScall | $0 | – | -75,000 | -100.0% | -0.66% | – |
| HTWR | Exit | HEARTWARE INTL INC | $0 | – | -50,000 | -100.0% | -0.71% | – |
| SRPT | Exit | SAREPTA THERAPEUTICS INCput | $0 | – | -100,000 | -100.0% | -0.89% | – |
| BIIB | Exit | BIOGEN INC | $0 | – | -7,500 | -100.0% | -0.89% | – |
| MYL | Exit | MYLAN N V | $0 | – | -44,000 | -100.0% | -0.93% | – |
| SPY | Exit | SPDR S&P 500 ETF TRput | $0 | – | -10,000 | -100.0% | -0.93% | – |
| ALGN | Exit | ALIGN TECHNOLGY INCput | $0 | – | -30,000 | -100.0% | -0.99% | – |
| TFX | Exit | TELEFLEX INCput | $0 | – | -15,000 | -100.0% | -1.07% | – |
| TFX | Exit | TELEFLEX INC | $0 | – | -15,000 | -100.0% | -1.07% | – |
| ARAY | Exit | ACCURAY INC | $0 | – | -441,300 | -100.0% | -1.16% | – |
| ACAD | Exit | ACADIA PHARMACEUTICALS INCcall | $0 | – | -100,000 | -100.0% | -1.27% | – |
| A | Exit | AGILENT TECHNOLOGIES INC | $0 | – | -90,000 | -100.0% | -1.63% | – |
| SPY | Exit | SPDR S&P 500 ETF TRcall | $0 | – | -20,000 | -100.0% | -1.87% | – |
| NUVA | Exit | NUVASIVE INCcall | $0 | – | -120,000 | -100.0% | -2.65% | – |
| ABBV | Exit | ABBVIE INC | $0 | – | -104,875 | -100.0% | -2.72% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-08-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ICU MED INC | 26 | Q2 2023 | 4.2% |
| NANOSTRING TECHNOLOGIES INC | 26 | Q2 2023 | 3.3% |
| VIEWRAY INC | 25 | Q2 2023 | 3.2% |
| LIVANOVA PLC | 23 | Q3 2023 | 3.8% |
| ALEXION PHARMACEUTICALS INC | 23 | Q1 2021 | 4.3% |
| INSPIRE MED SYS INC | 22 | Q3 2023 | 3.7% |
| BOSTON SCIENTIFIC CORP | 22 | Q3 2022 | 4.8% |
| INVACARE CORP | 22 | Q3 2021 | 2.8% |
| ESTABLISHMENT LABS HLDGS INC | 21 | Q3 2023 | 5.0% |
| INTERSECT ENT INC | 21 | Q2 2021 | 2.6% |
View PURA VIDA INVESTMENTS, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Stryve Foods Holdings, LLC | April 19, 2023 | 1,470,649 | 5.6% |
| ICAD INC | March 15, 2023 | 1,277,214 | 5.0% |
| ESTABLISHMENT LABS HOLDINGS INC. | February 14, 2023 | 1,002,767 | 4.1% |
| Pulmonx Corp | February 14, 2023 | 1,216,258 | 3.2% |
| Quotient LtdSold out | February 14, 2023 | 0 | 0.0% |
| Universe Pharmaceuticals INCSold out | February 14, 2023 | 0 | 0.0% |
| MedMen Enterprises, Inc. | April 29, 2022 | 139,755,072 | 21.4% |
| INVACARE CORPSold out | February 14, 2022 | 0 | 0.0% |
| MedAvail Holdings, Inc. | February 14, 2022 | 714,120 | 2.2% |
| TELA Bio, Inc. | February 14, 2022 | 564,120 | 3.9% |
View PURA VIDA INVESTMENTS, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2024-02-13 |
| SC 13D/A | 2023-12-29 |
View PURA VIDA INVESTMENTS, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.